Thymosin 4 and its derivatives (explicitly including TB-500) are listed under the S2 growth-factors category, and BPC-157 was added to the Prohibited List in 2022 under S0 (non-approved substances)
Science 376 , eabl4896 (2022)
In that case, you should give your doctor a call
Contraindicated in patients with a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia Syndromes (MEN 2) Not suitable for individuals with type 1 diabetes or diabetic ketoacidosis Should not be used alongside other GLP-1 receptor medications Gastric emptying may be delayed, requiring caution for procedures involving sedation or general anesthesia due to aspiration risk Use caution in those with a history of diabetic retinopathy 1-3 Consult your healthcare provider if you have a history of pancreatitis, as the medication may increase risk Serious side effects may involve hypoglycemia, kidney issues, or allergic reactions Avoid use during pregnancy and breastfeeding 1 Enhances glucose-dependent insulin secretion Suppresses glucagon secretion Slows gastric emptying Influences brain regions involved in appetite regulation, leading to reduced hunger and caloric intake Improves insulin sensitivity 1-3 Supports weight loss Helps to minimize internal inflammation and improves cardiometabolic health measures 5 Q: How long does it take to see results
Semaglutide therapy is initiated at a low dose, and the dose is increased gradually to allow the body to adjust to the medication
This review noted that ipamorelin was one of a number of GHS that can significantly improve body composition while ameliorating specific hypogonadal symptoms including fat gain and muscular atrophy [5]
